Financial News
Latest News about BLUE
Recent news which mentions BLUE
From Benzinga
With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023
April 24, 2023
From Benzinga
From Benzinga
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 13, 2023
From Benzinga
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
April 13, 2023
From Benzinga
Nasdaq Surges 100 Points; US Producer Prices Drop In March
April 13, 2023
From Benzinga
From Benzinga
From Motley Fool
Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio
April 06, 2023
From Motley Fool
S&P 500 Up 1%; Bluebird Bio Shares Plummet
March 29, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 29, 2023
From Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
From Benzinga
Nasdaq Rises 1%; US Pending Home Sales Increase In February
March 29, 2023
From Benzinga
Why Bluebird Bio Shares Are Plunging Today
March 29, 2023
From Benzinga
UniFirst, Progress Software, SomaLogic And Other Big Stocks Moving Lower On Wednesday
March 29, 2023
From Benzinga
US Stocks Open Higher, Dow Jumps Over 200 Points
March 29, 2023
From Benzinga
From Benzinga
From Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
From Benzinga
From Benzinga
1 Beaten-Down Stock That Has a Lot to Prove in 2023
February 08, 2023
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.